Study: Current treatments are not effective to treat severe asthma – TheHealthSite


Times of India

Study: Current treatments are not effective to treat severe asthma
TheHealthSite
The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, says a new study by an Indian-origin researcher. These unique features could point the way to new treatments.
Severe asthma fails to respond to treatmentTimes of India
Study could point the way to new treatments for people with severe asthmaNews-Medical.net

all 13 news articles »

View full post on asthma – Google News

Severe asthma fails to respond to treatment – Times of India


Times of India

Severe asthma fails to respond to treatment
Times of India
They used a computer model to identify links between interferon gamma and asthma-associated genes. As interferon gamma levels rose, the levels of a protein called secretory leukocyte protease inhibitor (SLPI) dropped. In follow-up experiments, the team …
Study: Current treatments are not effective to treat severe asthmaTheHealthSite
Study could point the way to new treatments for people with severe asthmaNews-Medical.net

all 13 news articles »

View full post on asthma – Google News

Study could point the way to new treatments for people with severe asthma – News-Medical.net


Times of India

Study could point the way to new treatments for people with severe asthma
News-Medical.net
The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those unique features could
Study: Current treatments are not effective to treat severe asthmaTheHealthSite
Severe asthma fails to respond to treatmentTimes of India

all 13 news articles »

View full post on asthma – Google News

Human Metapneumovirus Infection is Associated with Severe Respiratory Disease in Preschool Children with History of Prematurity.

Related Articles

Human Metapneumovirus Infection is Associated with Severe Respiratory Disease in Preschool Children with History of Prematurity.

Pediatr Neonatol. 2015 May 23;

Authors: Pancham K, Sami I, Perez GF, Huseni S, Kurdi B, Rose MC, Rodriguez-Martinez CE, Nino G

Abstract
BACKGROUND: Human metapneumovirus (HMPV) is a recently discovered respiratory pathogen of the family Paramyxoviridae, the same family as that of respiratory syncytial virus (RSV). Premature children are at high risk of severe RSV infections, however, it is unclear whether HMPV infection is more severe in hospitalized children with a history of severe prematurity.
METHODS: We conducted a retrospective analysis of the clinical respiratory presentation of all polymerase chain reaction-confirmed HMPV infections in preschool-age children (?5 years) with and without history of severe prematurity (<32 weeks gestation). Respiratory distress scores were developed to examine the clinical severity of HMPV infections. Demographic and clinical variables were obtained from reviewing electronic medical records.
RESULTS: A total of 571 preschool children were identified using polymerase chain reaction-confirmed viral respiratory tract infection during the study period. HMPV was identified as a causative organism in 63 cases (11%). Fifty-eight (n = 58) preschool-age children with HMPV infection were included in this study after excluding those with significant comorbidities. Our data demonstrated that 32.7% of children admitted with HMPV had a history of severe prematurity. Preschool children with a history of prematurity had more severe HMPV disease as illustrated by longer hospitalizations, new or increased need for supplemental O2, and higher severity scores independently of age, ethnicity, and history of asthma.
CONCLUSION: Our study suggests that HMPV infection causes significant disease burden among preschool children with a history of prematurity leading to severe respiratory infections and increasing health care resource utilization due to prolonged hospitalizations.

PMID: 26117550 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

FDA Panel Backs Mepolizumab for Severe Eosinophilic Asthma – Medscape


Medscape

FDA Panel Backs Mepolizumab for Severe Eosinophilic Asthma
Medscape
A typical characteristic of mild asthma is airway inflammation due to eosinophils, and this inflammation is closely associated with the risk for severe asthma exacerbations. Several products are approved for long-term maintenance treatment of asthma
FDA panel backs approval of GSK asthma drug in adultsReuters
Asthma Drug Targeting IL-5 Wins Partial Backing From FDA AdvisersMedPage Today
UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in StreetInsider.com
Healio
all 17 news articles »

View full post on asthma – Google News

UPDATE: Glaxo’s (GSK) Severe Asthma Drug Mepolizumab Found Effective in … – StreetInsider.com

UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in
StreetInsider.com
GlaxoSmithKline (NYSE: GSK) severe asthma drug, mepolizumab, is effective in adults, FDA panel says, according to Bloomberg. UPDATE – Last November, Glaxo announced that it filed regulatory submissions in the USA and Europe for mepolizumab for …

View full post on asthma – Google News

Asthma Therapeutics Market to 2020 – Personalized Treatment for Severe … – Medgadget.com (blog)


Medgadget.com (blog)

Asthma Therapeutics Market to 2020 – Personalized Treatment for Severe
Medgadget.com (blog)
The global prevalence of asthma, a chronic inflammatory disease of the airways, has risen considerably in recent decades and is expected to reach 400 million people by 2025. This high prevalence is a substantial contributor to healthcare costs and a

View full post on asthma – Google News